Black elderberry is rich in anthocyanins, chiefly cyanidin-3-glucoside and cyanidin-3-sambubioside. In laboratory work these flavonoids bind viral surface hemagglutinin and may modulate mucosal cytokine signaling. These mechanisms are largely preclinical, so they explain plausibility rather than prove benefit in people [4][5].
Anthocyanins have low oral bioavailability, with typically well under 1–2% of the dose appearing intact in plasma. Much of the effect may come from gut-derived phenolic metabolites such as protocatechuic acid. This is why standardized extracts, not raw juice volume, are the practical dosing unit, and why single-dose pharmacokinetics should not be over-interpreted [3][4].
The best human evidence is a 2019 meta-analysis of four randomized trials in 180 people, which found a large reduction in upper respiratory symptoms [1]. A randomized, double-blind ER influenza trial supports faster symptom resolution [2]. It does not show prevention of infection, and a role in herpesviral infection is unproven. Patients with confirmed influenza who are at high risk should still discuss oseltamivir with a clinician [2].
Try This Today
Pooled data from 4 randomized trials (180 participants) found black elderberry reduced upper respiratory symptoms with a large standardized effect (SMD about -1.81), though the trials were small and heterogeneous, so certainty is moderate at best.